Physician profile
Luis Manuel Abrante
NPI 1598548596
$770.23
in general payments reported to CMS, 2019-2025
17 companies · $303 in 2025
The $303 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $58.87 · 2024: $408 · 2025: $303.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $770.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $770.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $142.09 | 2024-2025 | |
| Novo Nordisk INC | $128.86 | 2023-2025 | Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $99.08 | 2024-2025 | Farxiga |
| Amgen INC. | $72.37 | 2023-2025 | Repatha, Otezla, Otezla |
| Pfizer INC. | $50.11 | 2023-2024 | |
| Glaxosmithkline, LLC. | $47.96 | 2024-2025 | Trelegy Ellipta, Arexvy |
| Eisai INC. | $25.17 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.58 | 2025 | Jardiance |
| Abbott Laboratories | $24.29 | 2025 | Freestyle Libre 3 |
| Bayer Healthcare Pharmaceuticals INC. | $24.01 | 2024 | |
| Merck Sharp & Dohme LLC | $21.80 | 2024 | Verquvo |
| Dexcom, INC. | $21.74 | 2024 | Dexcom G6 Transmitter |
| Xeris Pharmaceuticals, INC. | $20.17 | 2024 | Keveyis |
| Novartis Pharmaceuticals Corporation | $19.60 | 2024 | |
| Kowa Pharmaceuticals America, INC. | $17.03 | 2025 | Zoryve |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $16.76 | 2024 | |
| Sumitomo Pharma America, INC. | $14.61 | 2024 | Gemtesa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Abrante listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.